Commissioning 2.0: "What the New NHS Landscape Really Means for Pharma"
Commissioning 2.0 is here and it’s about to reshape how Pharma engages with the NHS. Kandarp Thakkar and Aliya Türk will be unpacking what the new commissioning landscape really means.
Live 1-hour webinar | Hosted by Soar Beyond
Monday April 27th 2026
13:00 - 14:00pm
Zoom
What We'll Cover
-
​Why commissioning is changing, and what the policy drivers really mean for pharma
-
What happens when specialised commissioning moves to ICBs and Clusters
-
How ICB clusters shape formularies, pathways and investment decisions
-
The future of IFRs and exceptional access routes in a devolved system
-
How ICBs are redefining value - beyond QALYs to population health and system impact
-
Practical steps pharma can take to engage effectively in the new landscape
Who Should Attend?
​​
-
Pharma market access, medical affairs & commercial leaders
-
NHS commissioners, ICB medicines leads & pathway managers
-
Brand, strategy & policy teams navigating the commissioning transition
Why Soar Beyond?
Soar Beyond works at the intersection of policy, commissioning and frontline delivery, supporting systems to translate strategy into action. In this session, we will share a practical, system-level perspective on how pharma can engage differently and more effectively to support sustainable innovation adoption.